[go: up one dir, main page]

AU2002324701A1 - Gene expression profiles in glomerular diseases - Google Patents

Gene expression profiles in glomerular diseases

Info

Publication number
AU2002324701A1
AU2002324701A1 AU2002324701A AU2002324701A AU2002324701A1 AU 2002324701 A1 AU2002324701 A1 AU 2002324701A1 AU 2002324701 A AU2002324701 A AU 2002324701A AU 2002324701 A AU2002324701 A AU 2002324701A AU 2002324701 A1 AU2002324701 A1 AU 2002324701A1
Authority
AU
Australia
Prior art keywords
gene expression
expression profiles
glomerular diseases
glomerular
diseases
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002324701A
Inventor
Ronald Falk
William E. Munger
Hitoshi Sasai
Hongwei Sun
Iwao Waga
Jun Yamamoto
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Japan Tobacco Inc
University of North Carolina at Chapel Hill
Original Assignee
Japan Tobacco Inc
University of North Carolina at Chapel Hill
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Japan Tobacco Inc, University of North Carolina at Chapel Hill filed Critical Japan Tobacco Inc
Publication of AU2002324701A1 publication Critical patent/AU2002324701A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Analytical Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AU2002324701A 2001-08-14 2002-08-14 Gene expression profiles in glomerular diseases Abandoned AU2002324701A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US31183701P 2001-08-14 2001-08-14
US60/311,837 2001-08-14
PCT/US2002/025766 WO2003016476A2 (en) 2001-08-14 2002-08-14 Gene expression profiles in glomerular diseases

Publications (1)

Publication Number Publication Date
AU2002324701A1 true AU2002324701A1 (en) 2003-03-03

Family

ID=23208719

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002324701A Abandoned AU2002324701A1 (en) 2001-08-14 2002-08-14 Gene expression profiles in glomerular diseases

Country Status (2)

Country Link
AU (1) AU2002324701A1 (en)
WO (1) WO2003016476A2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7253148B2 (en) * 2003-03-07 2007-08-07 The Research Foundation Of State University Of New York Human gene with immunoregulatory and anti-proliferative properties
US20050186577A1 (en) 2004-02-20 2005-08-25 Yixin Wang Breast cancer prognostics
US7608395B2 (en) * 2005-09-15 2009-10-27 Baylor Research Institute Systemic lupus erythematosus diagnostic assay

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998008528A1 (en) * 1996-08-30 1998-03-05 Biomeasure Incorporated Method of inhibiting fibrosis with a somatostatin agonist
US6114123A (en) * 1999-06-14 2000-09-05 Incyte Pharmaceuticals, Inc. Lipocalin family protein

Also Published As

Publication number Publication date
WO2003016476A3 (en) 2003-05-08
WO2003016476A2 (en) 2003-02-27

Similar Documents

Publication Publication Date Title
AU2002259196A1 (en) Gene expression profiling
AU2002253878A1 (en) Gene expression profiles in breast tissue
AU2002313559A1 (en) Genes
AU2002318298A1 (en) Defining external parameters in spreadsheets
AU2002365188A1 (en) Nucleic acid delivery and expression
AU2002364078A1 (en) Gene expression profiles in liver disease
AU2003217222A1 (en) In vivo gene transfer
AU2001270478A1 (en) Gene expression in biological conditions
AU7606100A (en) Gene expression profiles
GB0122232D0 (en) Gene expression
AU2002355857A1 (en) Gene associated with bone disorders
AU2002324701A1 (en) Gene expression profiles in glomerular diseases
AU2003239589A1 (en) Eta-1 gene and methods for use
AU2003294705A1 (en) NtSM GENE
AU2003275946A1 (en) Gene expression in biological conditions
AU2002953015A0 (en) Modified lacz gene
AU2002306951A1 (en) Gene regulation ii
AU2003267384A1 (en) Bhyd gene
AU2002324792A1 (en) Amplified gene involved in cancer
AU2003241762A1 (en) Dna shuflling
AU2002328863A1 (en) Oncosuppressive gene
AU2002337325A1 (en) Gene expression
AUPR232800A0 (en) Gene expression
AU2002346158A1 (en) Gene therapeutics
HK1063063A (en) Improved gene expression

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase